Magnolol ameliorates lipopolysaccharide-induced acute lung injury in rats through PPAR-γ-dependent inhibition of NF-kB activation

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 270-278

  Lin, Ming Hsien ^a,b   Chen, Meng Chuan ^c   Chen, Tso Hsiao ^d   Chang, Heng Yuan ^e   Chou, Tz Chong ^c,e,f,g  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute lung injury; Lipopolysaccharide; Magnolol; Peroxisome proliferator activated receptor gamma

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MAGNOLOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; BIPHENYL DERIVATIVE; CYTOKINE; LIGNAN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; LUNG EDEMA; LUNG LAVAGE; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PULMONARY EDEMA; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANILIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIPHENYL COMPOUNDS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; LIGNANS; LIPOPOLYSACCHARIDES; MALE; NEUTROPHIL INFILTRATION; NF-KAPPA B; OXIDATIVE STRESS; PEROXIDASE; PPAR GAMMA; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84934980563     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.05.051     Document Type: Article

References (33)

1. A.P. Wheeler, and G.R. Bernard Acute lung injury and the acute respiratory distress syndrome: a clinical review Lancet 369 2007 1553 1564
2. K. Tsushima, L.S. King, N.R. Aggarwal, A. De Gorordo, F.R. D'Alessio, and K. Kubo Acute lung injury review Intern. Med. 48 2009 621 631
3. D. Togbe, S. Schnyder-Candrian, B. Schnyder, E. Doz, N. Noulin, and L. Janot Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury Int. J. Exp. Pathol. 88 2007 387 391
4. M. Chopra, J.S. Reuben, and A.C. Sharma Acute lung injury: apoptosis and signaling mechanisms Exp. Biol. Med. 234 2009 361 371
5. H. Chen, C. Bai, and X. Wang The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine Expert Rev. Respir. Med. 4 2010 773 783
6. C.L. Tsai, Y.C. Lin, H.M. Wang, and T.C. Chou Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats J. Ethnopharmacol. 153 2014 197 206
7. B.P. Kota, T.H. Huang, and B.D. Roufogalis An overview on biological mechanisms of PPARs Pharmacol. Res. 51 2005 85 94
8. A.C. Wang, Dai, B. Luu, and D.J. Conrad Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation Am. J. Respir. Cell Mol. Biol. 24 2001 688 693
9. R.C. Reddy, V.G. Keshamouni, S.H. Jaigirdar, X. Zeng, T. Leff, and V.J. Thannickal Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-ligands Am. J. Physiol. Lung Cell. Mol. Physiol. 286 2004 L613 L619
10. M.A. Birrell, H.J. Patel, K. McCluskie, S. Wong, T. Leonard, and M.H. Yacoub PPAR-agonists as therapy for diseases involving airway neutrophilia Eur. Respir. J. 24 2004 18 23
11. A.H. Remels, R.C. Langen, H.R. Gosker, A.P. Russell, F. Spaapen, and J.W. Voncken PPAR gamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle Am. J. Physiol. Endocrinol. Metab. 297 2009 E174 E183
12. Y.J. Lee, Y.M. Lee, C.K. Lee, J.K. Jung, S.B. Han, and J.T. Hong Therapeutic applications of compounds in the Magnolia family Pharmacol. Ther. 130 2011 157 176
13. Y.C. Tsai, P.Y. Cheng, C.W. Kung, Y.J. Peng, T.H. Ke, and J.J. Wang Beneficial effects of magnolol in a rodent model of endotoxin shock Eur. J. Pharmacol. 641 2010 67 73
14. Y. Fu, B. Liu, N. Zhang, Z. Liu, D. Liang, and F.Y. Li Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways J. Ethnopharmacol. 145 2013 193 199
15. Y.C. Lin, Y.S. Lai, and T.C. Chou The protective effect of alpha-lipoic acid in lipopolysaccharide-induced acute lung injury is mediated by heme oxygenase-1 Evid. Based Complement. Alternat. Med. 2013 590363
16. Y.F. Ni, J.K. Kuai, Z.F. Lu, G.D. Yang, H.Y. Fu, and J. Wang Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression J. Surg. Res. 165 2011 e29 e35
17. J. Grommes, and O. Soehnlein Contribution of neutrophils to acute lung injury Mol. Med. 17 2011 293 307
18. R.B. Goodman, J. Pugin, J.S. Lee, and M.A. Matthay Cytokine-mediated inflammation in acute lung injury Cytokine Growth Factor Rev. 14 2003 523 535
19. W.L. Lee, and G.P. Downey Neutrophil activation and acute lung injury Curr. Opin. Crit. Care 7 2001 1 7
20. X. Yao, N. Chen, C.H. Ma, J. Tao, J.A. Bao, and C. Zong-Qi Ginkgo biloba extracts attenuate lipopolysaccharide-induced inflammatory responses in acute lung injury by inhibiting the COX-2 and NF-κB pathways Chin. J. Nat. Med. 13 2015 52 58
21. N. Niu, B. Li, Y. Hu, X. Li, J. Li, and H. Zhang Protective effects of scoparone against lipopolysaccharide-induced acute lung injury Int. Immunopharmacol. 23 2014 127 133
22. L.A. Moraes, L. Piqueras, and D. Bishop-Bailey Peroxisome proliferator-activated receptors and inflammation Pharmacol. Ther. 110 2006 371 385
23. R.B. Clark The role of PPARs in inflammation and immunity J. Leukoc. Biol. 71 2002 388 400
24. L.F. Wang, M. Patel, H.M. Razavi, S. Weicker, M.G. Joseph, and D.G. McCormack Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis Am. J. Respir. Crit. Care Med. 165 2002 1634 1639
25. C. Sittipunt, K.P. Steinberg, J.T. Ruzinski, C. Myles, S. Zhu, and R.B. Goodman Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome Am. J. Respir. Crit. Care Med. 163 2001 503 510
26. R. Gust, J.K. Kozlowski, A.H. Stephenson, and D.P. Schuster Role of cyclooxygenase-2 in oleic acid-induced acute lung injury Am. J. Respir. Crit. Care Med. 160 1999 1165 1170
27. H.S. Park, S.R. Kim, and Y.C. Lee Impact of oxidative stress on lung diseases Respirology 14 2009 27 38
28. J.C. Kim, Y.H. Lee, M.K. Yu, N.H. Lee, J.D. Park, and G. Bhattarai Anti-inflammatory mechanism of PPAR-γ on LPS-induced pulp cells: role of the ROS removal activity Arch. Oral Biol. 57 2012 392 400
29. P.P. Tak, and G.S. Firestein NF-kappaB: a key role in inflammatory diseases J. Clin. Invest. 107 2001 7 11
30. J.G. Wright, and J.W. Christman The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy Am. J. Respir. Med. 2 2003 211 219
31. J.M. Kyriakis, and J. Avruch Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 81 2001 807 869
32. H. Zhong, M.J. May, E. Jimi, and S. Ghosh The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 Mol. Cell 9 2002 625 636
33. J. Sun, R.D. Ramnath, L. Zhi, R. Tamizhselvi, and M. Bhatia Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways Am. J. Physiol. Cell Physiol. 294 2008 C1586 C1596